Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Insider Trading > F Michael Maclean > Profile

F Michael Maclean

Affiliations

  • at Verve Therapeutics Inc. (VERV), 2025-06-06
  • Chief Financial Officer at Avidity Biosciences Inc. (RNA), 2025-03-21
  • Chief Financial Officer at Akcea Therapeutics Inc. (AKCA), 2020-01-16
  • Svp, Chief Accounting Officer at Biogen Idec Inc. (BIIB), 2010-10-04
Insider Trading: Sales See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
RNA $31.06 7,935 $246,424.60 96,720 2025-03-20 Filing
RNA $28.59 1,665 $47,607.68 104,655 2025-01-21 Filing
RNA $28.59 1,622 $46,377.68 106,320 2025-01-21 Filing
RNA $32.66 11,151 $364,191.66 82,942 2024-12-18 Filing
RNA $45.33 13,875 $629,007.86 94,093 2024-11-06 Filing